Oral chemotherapy has evolved with several new agents such as capecitabine, UFT, eniluracil, etc. in active clinical trials or already approved for use in the western world. Several distinct issues, apart from the usual criteria
Sunil Sharma, MD
Advertisement
Articles by Sunil Sharma, MD
Advertisement
Latest Updated Articles
- Patient Selection for Oral Chemotherapy
January 2nd 2001
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Delays Decision on Subcutaneous Isatuximab in Multiple Myeloma
2
TERN-701 Earns FDA Breakthrough Therapy Designation in Ph+ CML
3
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
4
Exploring and Managing Gastrointestinal-Related CAR T-Cell Lymphomas
5